Given the role anti-MAG antibodies are thought to play in thepathogenesis of the neuropathy, treatments havefocused on decreasing circulating IgM by removal(eg, PLEX), inhibition (eg, IVIG) or reduction ofsynthesis (eg, corticosteroids, immunosuppressivedrugs, interferon-a or rituximab).